← Dashboard

Compliance Alert: Vonjo

Configure Methodology

Pending

This brand is pending video acquisition.

Analysis will begin once the promotional video is uploaded and indexed.

Vonjo | Swedish Orphan Biovitrum (Sobi) | DTC

FDA Letter Mar 9, 2026

Master

Visual

N/A

Efficacy

N/A

Fair Balance

N/A

Adeq Prov

N/A

Lifecycle

10%

Video Timeline

0s15s30s45s60s

No visual distractions detected

Recommendations

high

Escalate to regulatory affairs: FDA enforcement letter on file (Feb 6, 2026). Verify remediation status in PromoMats and confirm all content modifications address cited violations before next distribution.

FDA Enforcement Action on File

FDA Letter Feb 6, 2026 View PDF →

visual distraction

Pop-up book scenes of man petting dogs, eating ice cream, dancing with busker distract from risk information during major statement

fair balance

Ad suggests Vonjo improves social and emotional functioning (quality of life) not demonstrated in clinical trials

vague indication

Ad states Vonjo for adults with 'low' platelet counts without specifying the threshold (<50 x 10^9/L)

Video not available for preview